Pharma

Latest Content

Once more, with feeling

AI has proven its worth as a research tool and now it’s time to tap its potential for clinical trials, argues Tero Laulajainen. That places more, rather than less, onus on the human element.

In Depth

Enabling miniaturisations of automated organoid drug screens

Advanced cell-based models have grown in popularity for drug testing applications. The use of nanofibrillar cellulose hydrogels has enabled organoid drug screening that is largely animal free, automa…

Comment And Analysis

Once more, with feeling

AI has proven its worth as a research tool and now it’s time to tap its potential for clinical trials, argues Tero Laulajainen. That places more, rather than less, onus on the human element.

Interviews

Catherine Noakes and the Scientific Advisory Group for Emergencies (SAGE)

As part of a collaborative group of six British expert scientists, Catherine Noakes will join Jonathan Van-Tam and his team for the 2021 Royal Institutions Christmas  Lectures which will be recorded …